Relation of vigorexia to the use of anabolizing steroids in force training practices
Abstract
Introduction: The use of androgenetic anabolic steroids (AAS) has been reported as present in several sports modalities, associated with their use is the occurrence of autoimaging disorders. Vigorexia is one of these most commonly seen disorders. Objectives: To correlate vigorexia with the use of anabolic steroids in strength training practitioners (TP) within Sports Training Centers (CTE). Materials and Methods: a cross - sectional, quantitative, descriptive survey was carried out between October 2017 and June 2018 in two CTE, located in the peripheral zone of the city and in the noble zone. Composed of 40 volunteers, 20 of the peripheral zone (ZP) and 20 of the noble zone (ZN), classified as vigoréxicos, according to the Adonis Complex Questionnaire. The volunteers also completed a questionnaire with questions related to the use of anabolic steroids. For the comparison of the data, the Student's t-test was used for independent samples, and for the association between the qualitative data, the Chi-Square test was used. Results: ZN and ZP participants were aged 28.7 ± 4.77 years) and (32.42 ± 6.03 years) respectively (p = 0.03). A higher percentage of AAS use was observed in ZN (80%) when compared to ZP (45%) (p = 0.08). The most commonly used AAS were Durateston® (84%), Winstrol® (80%) and Deca Durabolin (44%). In both groups, the main factor for the use of steroids was aesthetics (p <0.05). As for medical follow-up during the use of AAS, there was no association between the groups, ie, regardless of social class, the demand was the same (p <0.05). Regarding medical follow-up for disease prevention, 100% of the participants in both groups did not do this type of procedure. Conclusion: Strength training practitioners with noble zone vigorexia use proportionally more anabolic steroids than those in the peripheral zone; There is a difference in the motivation of steroid use between the two groups; The most used steroids are Durateston®, stanazolol and Deca Durabolim®, with the main purpose related to esthetics.
References
-Abrahin, O. S. C.; Sousa, E. C. Esteroides anabolizantes androgênicos e seus efeitos colaterais: uma revisão crítico-científica. Rev. Educ. Fis. UEM. Maringá. Vol. 24. Num. 4. 2013. p. 669-679.
-Azevedo, A. P.; Ferreira, A. C.; Da Silva, P. P.; Caminha, I. D. O.; Freitas, C. D. Dismorfia muscular: A busca pelo corpo hipermusculoso. Motricidade. Vol. 08. Num. 01. 2012. p. 53-66. Calderon, F. Técnicas de Musculação. São Paulo. Marco Zero. 2006.
-Cole, J. C.; Smith, R.; Halford, J. C.; Wagstaff, G. F. A preliminary investigation into the relationship between anabolic androgenic steroids use and the symptoms of reverse anorexia in both current and ex users. Psychopharmacology. Vol. 166. Num. 4. 2003. p. 424-429.
-González-Martí, I.; Fernández-Bustos, J. G.; Jordán, O. R. C.; Sokolova, M. Dismorfia Muscular: detección del uso-abuso de esteroides anabolizantes androgénicos en una muestra española. Adicciones. Vol. 30. Num. 4. 2018. p. 243-250.
-Hildebrandt, T.; Lai, J. K.; Langenbucher, J. W.; Schneider, M.; Yehuda, R.; Pfaff, D. W. The diagnostic dilemma of pathological appearance and performance enhancing drug use. Drug and alcohol dependence. Vol. 114. Num. 1. 2011. p. 1-11.
-Iriart, J.A.B.; Chaves, J.C.; Orleans R.G. Culto ao corpo e uso de anabolizantes entre praticantes de musculação. Cad Saúde Pública. Vol. 25. Num. 4. 2009. p. 773-782.
-Kanayama, G.; Hudson, J.I.; Pope, JR. H. G. features of men with anabolic-androgenic steroid dependence: a comparison with nondependent aas users and with aas nonusers. drug and alcohol dependence. vol. 102. Bum. 1-3. 2009. p. 1030-1137.
-Kreider, R.B.; Wilborn, C.D.; Taylor, L.; Campbell, B.; Almada, A.L.; Collins, R.; Cooke, M.; Earnest, C.P.; Greenwood, M.; Kalman, D.S.; Kerksick, C.M.;Kleiner, S.M., Leutholtz, B.;Lopez, H.;Lowery, L.M.;Mendel, R.;Smith, A.;Spano, M.;Wildman, R.; Willoughby, D.S.; Ziegenfuss, T.N.; Antonio, J. Exercise e sport nutrition review: research e recommendations. Journal of the International Society of Sports Nutrition. Vol. 7. Num. 1. 2010. p. 1-43.
-Nogueira, F. R.S.; de Freitas Brito, A.; Vieira, T. I.; de Oliveira, C. V. C.; Gouveia, R. L. B. Prevalência de uso de recursos ergogênicos em praticantes de musculação na cidade de João Pessoa, Paraíba. Revista Brasileira de Ciências do Esporte. Vol. 37. Num. 1. 2015. p. 56-64.
-Olivardia, R.; Pope, H. G. Y.; Hudson, J. Muscle dysmorphia in male weightlifters: a case-control study. American Journal of Psychiatry. Vol. 157. Num. 8. 2000. p. 1291-1296.
-Pope, H. G. Y., Phillips, K. A., Olivardia, R. O Complexo de Adônis: a obsessão masculina pelo corpo. Tradução Sérgio Teixeira. Rio de Janeiro. Editora Campus. 2000.
-Pope, C. G.; Pope, H. G. Y., Menard, W., Fay, C.; Olivardia, R., Phillips, K. Clinical features of muscle dysmorphia among males with dysmorphic disorder. Body Image, Vol. 2. Num. 4. 2005. p. 395-399.
-Rocha, M.; Barthichoto, M.; Lopes, J.; Costa, K.; Nacif, M. Vigorexia: um distúrbio da imagem corporal. Lecturas Educación Fisica y Deportes, Revista digital. Buenos Aires. Vol. 18. Num. 181. 2013.
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with work simultaneously licensed under the Creative Commons Attribution License BY-NC which allows the sharing of the work with acknowledgment of the authorship of the work and initial publication in this journal.
- Authors are authorized to enter into additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to post and distribute their work online (eg, in institutional repositories or on their personal page) at any point before or during the editorial process, as this can bring about productive change as well as increase impact and impact. citation of published work (See The Effect of Free Access).
